Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-25
2010-06-29
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S356100, C548S373100, C548S375100, C514S403000
Reexamination Certificate
active
07745477
ABSTRACT:
Compounds of formula Iwherein R1, R2, R4, R5, A, B, D and n are as defined, and pharmaceutically acceptable salts thereof, processes for their preparation, their use as pharmaceuticals and pharmaceutical compositions comprising them.
REFERENCES:
patent: 7291621 (2007-11-01), Gao et al.
patent: 7300917 (2007-11-01), Nakade et al.
patent: 7572823 (2009-08-01), Conte et al.
patent: 2006/0148830 (2006-07-01), Terakado et al.
patent: WO 2004/031118 (2004-04-01), None
patent: WO 2005/102388 (2005-03-01), None
patent: WO 2005/100298 (2005-10-01), None
patent: WO 2006/013048 (2006-02-01), None
Applequist et al., J. Org. Chem., 41, pp. 2262-2266 (1976).
Kelley et al., J. Chem. Res. Miniprint, 12, pp. 2701-2733 (1997).
Le Goff et al., Pharmacology & Therapeutics, 101, pp. 17-38 (2004).
Okamoto et al., Nature, 406, pp. 203-207 (2000).
Liu et al., J. Med. Chem., 46, pp. 4232-4235 (2003).
Austin et al., J. Org. Chem., 46, pp. 2280-2286 (1981).
Bruckner, D., et al., Bioorganic & Medicinal Chemistry Letters, vol. 15, No. 15, pp. 3611-3614 (2005), XP004969906.
Conte Aurelia
Kuehne Holger
Luebbers Thomas
Mattei Patrizio
Maugeais Cyrille
Hoffman-La Roche Inc.
Johnston George W.
Remy Brian C.
Shameem Golam M
Tramaloni Dennis P.
LandOfFree
Heteroaryl and benzyl amide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl and benzyl amide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl and benzyl amide compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4228495